Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹10.7 CrAccepted-AOC 6TH FLOOR BUILDING NO 8 TOWER C DLF CYBER CITY PHASE II MOTI NAGAR GURGAON WEST DELHI DELHI 122002 | GURUGRAM | HARYANA | 122002 | ₹10.7 Cr Quoted ₹30,975 | L1 | Accepted-AOC Awarded |
| 2 | L1₹19.1 CrAccepted-AOC 1ST AND 2ND FLOOR NXT TOWER 2 EMBASSY MANYATA BUSINESS PARK NAGAVARA VILLAGE KASABA HOBLI BANGALORE KARNATAKA INDIA 560045 | BANGALORE | BANGALORE | KARNATAKA | 560045 | ₹19.1 Cr Quoted ₹82,551 | L1 | Accepted-AOC Awarded |
| 3 | L2₹4.9 CrAccepted-AOC CORPORATE HOUSE NEAR SOLA BRIDGE S G HIGHWAY THALTEJ AHMEDABAD GUJARAT 380054 | AHMADABAD | GUJARAT | 380054 | ₹4.9 Cr Quoted ₹9.45 | L2 | Accepted-AOC Awarded |
| 4 | L1₹1,247.40Rejected-AOC DHIRUBHAI AMBANI LIFE SCIENCES CENTRE R 282 ITC AREA OF MIDC THANE BELAPUR ROAD RABALE NAVI MUMBAI 400701 | NAVI MUMBAI | THANE | MAHARASHTRA | 400701 | ₹1,247.40 | L1 | Rejected-AOC Not Awarded |
| 5 | L2₹1,550.85Rejected-AOC | ₹1,550.85 | L2 | Rejected-AOC Not Awarded |
| Sl No | Description | Qty | Unit | Novo Nordisk India Private Limited L5 | Intas Pharmaceuticals Ltd L1 | Takeda Biopharmaceuticals India Private Limited L4 | M/s Grifols India Healthcare Private L3 | Reliance Life Sciences Pvt. Ltd. L2 |
|---|---|---|---|---|---|---|---|---|
| 1.00 | Anti Hemophillic Factor VII (Human Recombinant Coagulation factor activated 2 mg) Injection 2mg,vial/ampoule | 1 | vial/amp. | 78,620 ₹82,551 | - | - | - | - |
| 2.00 | Purified Freeze – Dried Human Coagulation Factor VIII, Virus inactivated Injection 250 IU | 1 | Single Unit | - | - | - | 1,477 ₹1,550.85 | 1,188 ₹1,247.40 |
| 3.00 | Anti Hemophillic Factor VIII Inhibitor by passing agent OR Anti Inhibitor Coagulant complex (other name of FEIBA) Injection 500 IU, VIAL/AMPOULE | 1 | Vial/Ampoule | - | - | 29,500 ₹30,975 | - | - |
| 4.00 | Anti Hemophillic Factor IX vial Injection size 500 IU | 1 | Single Unit | - | 9 ₹9.45 | 8.3 ₹8.71 | - | - |
Tender Value
₹49 Cr
EMD Value
₹2 L
Closing Date
6 Aug 2024, 1:00 pmClosed
MD HMSCL
HMSCL, DHL Square, 5th Floor, IT Park, Sector 22, Panchkula
Online Tender for the Rate Contract for the supply of Medicines to Various Hospitals of Government of Haryana for a Period of Two Years For Group A Medicines.
2024_HBC_383426_1
283/Tend/GPA/2024-25/3/4-A
Open Tender
Miscellaneous Goods
60 days
HMSCL, DHL Square, 5th Floor, IT Park, Sector 22
Please refer tender document
2 documents required · 2 mandatory
₹5,000
Yes
₹2 L
Yes
14 Oct 2025
26 Jun 2024
6 Aug 2024
26 Jun 2024
6 Aug 2024
26 Jun 2024
26 Jun 2024 - 3 Jul 2024
Anti Hemophillic Factor VII (Human Recombinant Coagulation factor activated 2 mg) Injection 2mg,vial/ampoule
Purified Freeze – Dried Human Coagulation Factor VIII, Virus inactivated Injection 250 IU
Anti Hemophillic Factor VIII Inhibitor by passing agent OR Anti Inhibitor Coagulant complex (other name of FEIBA) Injection 500 IU, VIAL/AMPOULE
Anti Hemophillic Factor IX vial Injection size 500 IU
Reliance Life Sciences Pvt. Ltd. (BID ID -1120182)
M/s Grifols India Healthcare Private (BID ID -1107822)
Takeda Biopharmaceuticals India Private Limited (BID ID -1113686)
Novo Nordisk India Private Limited (BID ID -1105903)
Takeda Biopharmaceuticals India Private Limited
Reliance Life Sciences Pvt. Ltd.
stage.html
html • 0.06 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
fin_eval.pdf
aoc.pdf
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Download all tender documents and submit your bid